Mayo Clinic Platform Enhances Cancer Research Capabilities

New features in Mayo Clinic Platform_Orchestrate provide researchers faster access to standardized, real-world cancer data.

Published on Feb. 12, 2026

Got story updates? Submit your updates here. ›

Mayo Clinic announced new capabilities within its Mayo Clinic Platform_Orchestrate that make it more efficient for researchers to access standardized, real-world cancer data from Mayo Clinic and participating partners. This allows researchers to generate insights that can accelerate cancer research and improve patient care. The platform now uses an industry-leading, standardized framework to organize complex cancer information, known as Observational Medical Outcomes Partnership (OMOP) Oncology, which presents de-identified data in a consistent, structured and research-ready format.

Why it matters

Developing new cancer therapies is a long and complex process, but Orchestrate's capabilities can help shorten this timeline by giving researchers faster access to high-quality, real-world cancer data. The standardized OMOP Oncology model allows researchers to analyze complex cancer data more rapidly, accurately and on a larger scale than before, supporting the development of next-generation cancer therapies.

The details

Orchestrate is now using the OMOP Oncology model, a product of the global Observational Health Data Sciences and Informatics (OHDSI) initiative, to present de-identified data in a consistent, structured and research-ready format. This includes standardized information such as tumor characteristics, biomarkers, staging, treatments, progression and outcomes. Nemesis Health, a research and technology service provider for Mayo Clinic Platform, contributed to the development of OMOP Oncology capabilities on Orchestrate. This year, Mayo Clinic Platform will also incorporate tokenization, a technology that connects de-identified information from across a patient's care experience to provide a more comprehensive understanding of a patient's cancer care pathway.

  • Mayo Clinic Platform_Orchestrate was launched in 2025.
  • The new OMOP Oncology capabilities were announced in February 2026.

The players

Mayo Clinic

A nonprofit organization committed to clinical practice, education and research, providing expert, whole-person care to patients from all 50 states and nearly 140 countries.

Mayo Clinic Platform_Orchestrate

A platform within the Mayo Clinic Platform that provides researchers with access to standardized, real-world cancer data to accelerate research and improve patient care.

Observational Health Data Sciences and Informatics (OHDSI)

A global, multi-stakeholder, interdisciplinary collaborative that aims to improve health by empowering a community to collaboratively generate the evidence that promotes better health decisions and better care.

Nemesis Health

A research and technology service provider that contributed to the development of OMOP Oncology capabilities on Mayo Clinic Platform_Orchestrate.

Elisabeth Heath, M.D.

Chair of the Department of Oncology at Mayo Clinic.

Got photos? Submit your photos here. ›

What they’re saying

“The integration of OMOP Oncology into Mayo Clinic Platform has the power to accelerate discovery, improve clinical trial design, unlock real-world insights and support the development of next-generation therapies for patients worldwide.”

— Elisabeth Heath, M.D., Chair of the Department of Oncology at Mayo Clinic (Mirage News)

“Orchestrate strengthens Mayo Clinic's commitment to advancing cancer care through data-driven innovation. By combining trusted data, advanced artificial intelligence and Mayo Clinic's scientific expertise, these capabilities help unlock deeper insights, accelerate research and ultimately, bring new therapies to patients faster.”

— Maneesh Goyal, Chief Operating Officer, Mayo Clinic Platform (Mirage News)

What’s next

Mayo Clinic Platform plans to incorporate tokenization technology in 2023, which will connect de-identified information from across a patient's care experience to provide researchers with a more comprehensive understanding of a patient's cancer care pathway.

The takeaway

The enhanced capabilities of Mayo Clinic Platform_Orchestrate, including the integration of the OMOP Oncology model, demonstrate Mayo Clinic's commitment to accelerating cancer research and improving patient care through data-driven innovation. By providing researchers with faster access to standardized, real-world cancer data, the platform has the potential to shorten the timeline for developing new cancer therapies and unlock deeper insights that can lead to better treatment outcomes for patients.